Correlation Between Pfizer and Context Therapeutics
Can any of the company-specific risk be diversified away by investing in both Pfizer and Context Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Context Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Context Therapeutics, you can compare the effects of market volatilities on Pfizer and Context Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Context Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Context Therapeutics.
Diversification Opportunities for Pfizer and Context Therapeutics
-0.58 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Pfizer and Context is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Context Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Context Therapeutics and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Context Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Context Therapeutics has no effect on the direction of Pfizer i.e., Pfizer and Context Therapeutics go up and down completely randomly.
Pair Corralation between Pfizer and Context Therapeutics
Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Context Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 4.11 times less risky than Context Therapeutics. The stock trades about -0.04 of its potential returns per unit of risk. The Context Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 68.00 in Context Therapeutics on December 5, 2024 and sell it today you would earn a total of 15.90 from holding Context Therapeutics or generate 23.38% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Pfizer Inc vs. Context Therapeutics
Performance |
Timeline |
Pfizer Inc |
Context Therapeutics |
Pfizer and Context Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pfizer and Context Therapeutics
The main advantage of trading using opposite Pfizer and Context Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Context Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Context Therapeutics will offset losses from the drop in Context Therapeutics' long position.Pfizer vs. Emergent Biosolutions | Pfizer vs. Bausch Health Companies | Pfizer vs. Neurocrine Biosciences | Pfizer vs. Teva Pharma Industries |
Context Therapeutics vs. Terns Pharmaceuticals | Context Therapeutics vs. Amylyx Pharmaceuticals | Context Therapeutics vs. Acumen Pharmaceuticals | Context Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |